Information Journal Paper
APA:
Copy. (2020). Cost-effectiveness of cladribine tablets versus fingolimod in patients with highly active relapsing multiple sclerosis in Portugal. JOURNAL OF MEDICAL ECONOMICS, 23(5), 484-491. SID. https://sid.ir/paper/658687/en
Vancouver:
Copy. Cost-effectiveness of cladribine tablets versus fingolimod in patients with highly active relapsing multiple sclerosis in Portugal. JOURNAL OF MEDICAL ECONOMICS[Internet]. 2020;23(5):484-491. Available from: https://sid.ir/paper/658687/en
IEEE:
Copy, “Cost-effectiveness of cladribine tablets versus fingolimod in patients with highly active relapsing multiple sclerosis in Portugal,” JOURNAL OF MEDICAL ECONOMICS, vol. 23, no. 5, pp. 484–491, 2020, [Online]. Available: https://sid.ir/paper/658687/en